Switzerland· 68217002
Amikacin Ideogen
A amikacin product containing amikacinum, natrium, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Amikacin is registered in 15 of 19 countries.
Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Amikacin · ATC J01GB06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- amikacinum, natrium
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- J01GB06
- ATC class
- Amikacin
- Defined daily dose
- 0.59 g, Inhal
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806821700295 Durchstf 2 mlCHF 96.9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
253 interactions on record for amikacin.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amikacin · interactions on record
253 records
- 50 severe
- 133 moderate
- 2 minor
- 68 info
Most severe, free to view
- Magnesium sulfateA06AD04severe
- MannitolA06AD16severe
- Polymyxin BA07AA05severe
- Magnesium sulfateA12CC02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01GB06
Amikacin, as other registers publish it.
- DenmarkAmikacin "Afortas"2care4 Generics ApS
- DenmarkAmikacin "Macure"Macure Pharma ApS
- DenmarkAmikacin "Medartuum"Medartuum AB
- DenmarkAmikacin "Orifarm"Orifarm A/S
- IrelandAmikacin 125 mg/ml Solution for injection/infusionNoridem Enterprises Limited
- IrelandAmikacin 250 mg/ ml Solution for injection/infusionAthlone Pharmaceuticals Limited
- IrelandAmikacin 250 mg/ml Solution for injection/infusionNoridem Enterprises Limited
- United KingdomAmikacin 25mg/5ml solution for injection ampoulesSpecial Order
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6a846a0-4d7b-4cf1-92cd-e5067e76382c GET /v1/drugs/c6a846a0-4d7b-4cf1-92cd-e5067e76382c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "amikacinum 500 mg",
"valid_from": "2025-02-01",
"limitations": null,
"galenic_form": "Inf Konz 500 mg/2ml",
"therapeutic_area": null,
"sl_inclusion_date": "2025-02-01",
"self_retention_pct": 10
}See everything about amikacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.